Clinical Significance of Ubiquitin-associated Protein 2-like in Patients with Uterine Cervical Cancer

Kosuke Yoshida, Hiroaki Kajiyama, Eri Inami, Satoshi Tamauchi, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kimihiro Nishino, Fumi Utsumi, Kaoru Niimi, Shiro Suzuki, Kiyosumi Shibata, Akihiro Nawa, Fumitaka Kikkawa

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Background: Ubiquitin-associated protein 2-like (UBAP2L) has been demonstrated to be associated with the progression of multiple types of cancer. However, the function of UBAP2L in uterine cervical cancer remains unclear. Materials and Methods: Between 2005 and 2015, 84 patients who underwent surgery were included in this study. The patients were stratified into two groups on the basis of immunohistochemical staining for UBAP2L, and survival analysis was performed. Moreover, loss-of-function analysis was performed using the cervical cancer cell lines CaSki and SiHa. Results: Based on immunohistochemistry, the overall survival in patients with low UBAP2L expression was significantly longer than that of those with high UBAP2L expression (p=0.045). The in vitro experiment revealed that knockdown of UBAP2L remarkably inhibited cell proliferation in both live cell imaging and the MTS assay. Conclusion: Patients with high UBAP2L expression had unfavorable prognosis and UBAP2L appears to play an important role in proliferation.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalIn Vivo
Issue number1
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology


Dive into the research topics of 'Clinical Significance of Ubiquitin-associated Protein 2-like in Patients with Uterine Cervical Cancer'. Together they form a unique fingerprint.

Cite this